Assertion: angina | /r/HasProperty | angina pectoris
Facets:
value: more formally
type: DEGREE
value: not improperly
type: MANNER
Source sentences:
text: DUBLIN--(BUSINESS WIRE)--The "Angina (Angina Pectoris) - Pipeline Review
text: It is more formally known as angina pectoris.
text: Angina also is called angina pectoris.
text: The seat of it, and sense of strangling and anxiety with which it is attended, may make it not improperly be called angina pectoris.
text: This latest Pharmaceutical and Healthcare disease pipeline guide Angina (Angina Pectoris) -
text: Pipeline Review, H1 2020, provides an overview of the Angina (Angina Pectoris) (Cardiovascular) pipeline landscape.
text: This Pharmaceutical and Healthcare latest pipeline guide Angina (Angina Pectoris) -
text: The Angina (Angina Pectoris) (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Angina (Angina Pectoris) and features dormant and discontinued projects.
text: Angina (Angina Pectoris)
text: Angina (Angina Pectoris) - Overview
text: Angina (Angina Pectoris) - Therapeutics Development
text: Angina (Angina Pectoris) - Therapeutics Assessment
text: Angina (Angina Pectoris)
text: Angina (Angina Pectoris)
text: Angina (Angina Pectoris)
text: Angina (Angina Pectoris) - Discontinued Products
text: Angina (Angina Pectoris) -
text: This latest Pharmaceutical and Healthcare disease pipeline guide Angina (Angina Pectoris) -
text: Pipeline Review, H1 2020, provides an overview of the Angina (Angina Pectoris) (Cardiovascular) pipeline landscape.
text: This Pharmaceutical and Healthcare latest pipeline guide Angina (Angina Pectoris) -
text: The Angina (Angina Pectoris) (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Angina (Angina Pectoris) and features dormant and discontinued projects.
text: Angina (Angina Pectoris)
text: Angina (Angina Pectoris) - Overview
text: Angina (Angina Pectoris) - Therapeutics Development
text: Angina (Angina Pectoris) - Therapeutics Assessment
text: Angina (Angina Pectoris)
text: Angina (Angina Pectoris)
text: Angina (Angina Pectoris)
text: Angina (Angina Pectoris) - Discontinued Products
text: Angina (Angina Pectoris) -
text: This latest Pharmaceutical and Healthcare disease pipeline guide Angina (Angina Pectoris) -
text: Pipeline Review, H1 2020, provides an overview of the Angina (Angina Pectoris) (Cardiovascular) pipeline landscape.
text: This Pharmaceutical and Healthcare latest pipeline guide Angina (Angina Pectoris) -
text: The Angina (Angina Pectoris) (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Angina (Angina Pectoris) and features dormant and discontinued projects.
text: Angina (Angina Pectoris)
text: Angina (Angina Pectoris) - Overview
text: Angina (Angina Pectoris) - Therapeutics Development
text: Angina (Angina Pectoris) - Therapeutics Assessment
text: Angina (Angina Pectoris)
text: Angina (Angina Pectoris)
text: Angina (Angina Pectoris)
text: Angina (Angina Pectoris) - Discontinued Products
text: Angina (Angina Pectoris) -
text: Angina (Angina Pectoris) -
text: Pipeline Review, H1 2020This latest Pharmaceutical and Healthcare disease pipeline guide Angina (Angina Pectoris) -
text: Pipeline Review, H1 2020, provides an overview of the Angina (Angina Pectoris) (Cardiovascular) pipeline landscape.
text: This Pharmaceutical and Healthcare latest pipeline guide Angina (Angina Pectoris) -
text: The Angina (Angina Pectoris) (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Angina (Angina Pectoris) and features dormant and discontinued projects.
text: Angina (Angina Pectoris)
text: Pipeline Review, H1 2020, provides comprehensive information on the therapeutics under development for Angina (Angina Pectoris) (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
text: The Angina (Angina Pectoris) (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Angina (Angina Pectoris) and features dormant and discontinued projects.
text: Find and recognize significant and varied types of therapeutics under development for Angina (Angina Pectoris) (Cardiovascular).
text: Formulate corrective measures for pipeline projects by understanding Angina (Angina Pectoris)
text: Pipeline Review, H1 2020, provides comprehensive information on the therapeutics under development for Angina (Angina Pectoris) (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
text: The Angina (Angina Pectoris) (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Angina (Angina Pectoris) and features dormant and discontinued projects.
text: Find and recognize significant and varied types of therapeutics under development for Angina (Angina Pectoris) (Cardiovascular).
text: Formulate corrective measures for pipeline projects by understanding Angina (Angina Pectoris)
text: Stable Angina (Angina of effort, Angina Pectoris) is one of the forms of coronary (ischemic) heart disease; this condition is characterized by chest pain and is common in middle-aged and senior people.
text: Pipeline Review, H1 2020, provides comprehensive information on the therapeutics under development for Angina (Angina Pectoris) (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
text: The Angina (Angina Pectoris) (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Angina (Angina Pectoris) and features dormant and discontinued projects.
text: Find and recognize significant and varied types of therapeutics under development for Angina (Angina Pectoris) (Cardiovascular).
text: Formulate corrective measures for pipeline projects by understanding Angina (Angina Pectoris)
text: ’ provides a comprehensive overview of the drugs that are in the R&D pipeline by indication or molecule for Angina (Angina Pectoris).
text: The report also covers additional insights such as epidemiology overview and current market scenario for Angina (Angina Pectoris).
text: The pipeline guide provides a snapshot of the global therapeutic landscape of Angina (Angina Pectoris) (Cardiovascular).
text: The pipeline guide reviews pipeline therapeutics for Angina (Angina Pectoris) (Cardiovascular) by companies and universities/research institutes based on information derived from company and industry-specific sources.
text: The pipeline guide reviews key companies involved in Angina (Angina Pectoris)
text: The pipeline guide evaluates Angina (Angina Pectoris) (Cardiovascular) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
text: The pipeline guide reviews latest news related to pipeline therapeutics for Angina (Angina Pectoris) (Cardiovascular)
text: Find and recognize significant and varied types of therapeutics under development for Angina (Angina Pectoris) (Cardiovascular).
text: Formulate corrective measures for pipeline projects by understanding Angina (Angina Pectoris)
text: Pipeline Review, H1 2020, provides comprehensive information on the therapeutics under development for Angina (Angina Pectoris) (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
text: The Angina (Angina Pectoris) (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Angina (Angina Pectoris) and features dormant and discontinued projects.
text: It is more formally known as angina pectoris.
text: Angina is also known as angina pectoris, which means “squeezing of chest” in the latin language.